drugset / Trial / NCT01147055

Estimation Of Effect Of Rifampin On Pharmacokinetics Of Crizotinib In Healthy Volunteers

NCT01147055

Phase 1 Completed 15 enrolled Pfizer
Non-randomizedCrossoverOpen-label

Summary

The purpose of this study is to estimate the effect of multiple doses of Rifampin on the single dose pharmacokinetics of Crizotinib in healthy volunteers.

Timeline

Start
2010-07
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Crizotinib Small molecule 250 mg
Subject Rifampin Small molecule 600 mg Oral

Indications

No indication recorded.